Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity

SIMPLE SUMMARY: Alzheimer’s disease (AD) remains a major challenge for the healthcare system worldwide and, to date, no curative treatment is available. This disease is an irreversible progressive dementia that harms memory and cognitive functions, weakening the ability to carry out tasks by themsel...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina-Vera, Dina, Rosell-Valle, Cristina, López-Gambero, Antonio J., Navarro, Juan A., Zambrana-Infantes, Emma N., Rivera, Patricia, Santín, Luis J., Suarez, Juan, Rodríguez de Fonseca, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694492/
https://www.ncbi.nlm.nih.gov/pubmed/33167441
http://dx.doi.org/10.3390/biology9110377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694492/
https://www.ncbi.nlm.nih.gov/pubmed/33167441
http://dx.doi.org/10.3390/biology9110377

Ejemplares similares